MMP2 and atherosclerosis: A previous animal study demonstrated that montelukast inhibited the development of atherosclerosis in association with decreased expression of MMP-2 and MMP-9 [27], and another experimental study indicated that montelukast produced anti-atherogenic effects related to MCP-1 downregulation [28].